Index
RUT
Market Cap
504.91M
Enterprise Value
117.43M
Income
-210.53M
Sales
70.92M
Book/sh
2.04
Cash/sh
2.18
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
317
IPO
Nov 11, 2015
P/E
-
Forward P/E
-
PEG
-
P/S
7.12
P/B
1.26
P/C
1.17
P/FCF
-
EV/EBITDA
-
EV/Sales
1.66
Quick Ratio
8.38
Current Ratio
8.38
Debt/Eq
0.11
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
-1.07
EPS next Y
-1.29
EPS next Q
-0.32
EPS this Y
8.52%
EPS next Y
-16.15%
EPS next 5Y
-1.21%
EPS past 3/5Y
16.10% 20.52%
Sales past 3/5Y
127.08% 16.31%
EPS Y/Y TTM
-45.17%
Sales Y/Y TTM
-35.07%
EPS Q/Q
5.55%
Sales Q/Q
72.95%
Insider Own
16.18%
Insider Trans
-0.08%
Inst Own
83.31%
Inst Trans
-0.71%
ROA
-56.19%
ROE
-78.80%
ROIC
-47.76%
Gross Margin
86.99%
Oper. Margin
-320.94%
Profit Margin
-296.86%
SMA20
-21.45%
SMA50
-27.50%
SMA200
-61.54%
Trades
Shs Outstand
197.21M
Shs Float
165.32M
52W High
21.73 -88.22%
52W Low
2.68 -4.48%
Volatility
7.61% 7.63%
ATR (14)
0.23
RSI (14)
25.98
Beta
-1.25
Rel Volume
0.73
Avg Volume
3.11M
Volume
2,283,200
Perf Week
-18.21%
Perf Month
-23.58%
Perf Quarter
-50.00%
Perf Half Y
-59.87%
Perf YTD
-84.94%
Perf Year
-62.10%
Perf 3Y
-50.77%
Perf 5Y
-40.60%
Perf 10Y
-93.25%
Prev Close
2.72
Price
2.56
Change %
-5.88%
Analysts 16 incl. previous ratings
Rating Distribution 15 Buy · 1 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 16, 2026 Initiated W William Blair
Outperform Oct 15, 2026 Initiated U UBS
Buy $11 +329.7% Oct 01, 2026 Initiated L Ladenburg Thalmann
Buy $10 +290.6% Sep 23, 2026 Resumed J JP Morgan
Neutral Apr 29, 2026 Resumed T Truist
Buy $15 +485.9% Feb 05, 2026 Initiated B BofA Securities
Buy $38 +1,384.4% Dec 12, 2025 Reiterated W Wedbush
Outperform $20 → $33 +1,189.1% Dec 09, 2025 Upgrade R RBC Capital Mkts
Sector Perform → Outperform $27 +954.7% Oct 20, 2025 Initiated W Wells Fargo
Overweight $18 +603.1% Aug 04, 2025 Initiated C Canaccord Genuity
Buy $19 +642.2% Jul 28, 2025 Initiated O Oppenheimer
Outperform $24 +837.5% Jul 16, 2025 Initiated C Citigroup
Buy $16 +525.0% Jun 11, 2025 Resumed R Raymond James
Outperform $14 +446.9% Apr 29, 2025 Initiated C Cantor Fitzgerald
Overweight $10 +290.6% Apr 08, 2025 Initiated W Wedbush
Outperform $18 +603.1% Feb 25, 2025 Initiated J Jefferies
Buy $26 +915.6% Oct 16, 2024 Upgrade R Raymond James
Outperform → Strong Buy $22 +759.4% Sep 27, 2024 Resumed J JP Morgan
Overweight $10 → $13 +407.8% Sep 19, 2024 Initiated R B. Riley Securities
Buy $11 +329.7% Sep 09, 2024 Initiated J JP Morgan
Overweight $10 +290.6%
Show Previous Ratings
Nov-13-26 08:30AM
Nov-11-26 08:30AM
Oct-27-26 10:49AM
(Earnings Whispers)
+7.48%
07:35AM
07:30AM
08:30AM
Loading…
Oct-20-26 08:30AM
Oct-19-26 08:30AM
Oct-13-26 08:30AM
Oct-01-26 12:04PM
07:30AM
Sep-30-26 07:30AM
Sep-23-26 07:30AM
Sep-22-26 07:30AM
Sep-21-26 05:06PM
Sep-03-26 04:05PM
(GlobeNewswire)
-3.69%
+3.40%
08:30AM
Loading…
Aug-13-26 08:30AM
Aug-10-26 08:30AM
Aug-05-26 04:05PM
Aug-04-26 08:30AM
Jul-30-26 05:03PM
07:43AM
07:30AM
Jul-23-26 08:30AM
Jul-07-26 04:15PM
Jun-24-26 08:30AM
Jun-02-26 08:30AM
Jun-01-26 08:30AM
May-20-26 06:43AM
May-19-26 09:49AM
May-18-26 04:30PM
04:05PM
Loading…
May-13-26 04:05PM
Apr-29-26 03:05AM
Apr-28-26 07:37AM
(Associated Press)
+8.36%
07:30AM
Apr-22-26 08:30AM
Apr-21-26 04:01PM
Apr-15-26 04:01PM
Apr-03-26 01:45PM
Mar-27-26 08:35AM
Mar-26-26 02:48PM
12:30PM
09:40AM
09:40AM
(Investor's Business Daily)
07:30AM
06:46AM
Mar-05-26 08:30AM
Mar-02-26 07:05AM
Feb-28-26 01:26PM
02:14AM
Feb-27-26 12:39PM
Feb-26-26 04:09PM
12:15PM
07:49AM
(Associated Press Finance)
07:30AM
Feb-23-26 08:30AM
Feb-22-26 06:15AM
Feb-19-26 08:30AM
Feb-18-26 07:38PM
02:02AM
Feb-16-26 12:23PM
Feb-07-26 03:33AM
Feb-05-26 10:12AM
Feb-03-26 12:30PM
Feb-02-26 02:16PM
07:30AM
03:31AM
Jan-12-26 07:30AM
Jan-06-26 04:28PM
(Investor's Business Daily)
11:26AM
07:06AM
Jan-05-26 08:30AM
Jan-02-26 10:50AM
Dec-31-25 11:25AM
Dec-30-25 11:46PM
Dec-22-25 10:18PM
Dec-17-25 09:45AM
Dec-14-25 02:40PM
Dec-11-25 04:28PM
(Investor's Business Daily)
-17.20%
10:15AM
07:13AM
(Investor's Business Daily)
Dec-10-25 05:27PM
Dec-09-25 09:50PM
07:39PM
02:24PM
Dec-08-25 06:50PM
05:01PM
04:51PM
04:09PM
(Investor's Business Daily)
04:01PM
03:44PM
12:46PM
07:30AM
05:32AM
Dec-07-25 04:00PM
Nov-16-25 10:13PM
Nov-13-25 06:00AM
Nov-10-25 08:45AM
07:43AM
(Associated Press Finance)
07:30AM
Nov-07-25 08:30AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wagner Heidi L Director Aug 11 '26 Option Exercise 5.97 7,000 41,790 51,930 Aug 13 09:00 PM Wagner Heidi L Director Aug 11 '26 Sale 6.01 7,000 42,070 44,930 Aug 13 09:00 PM Rawcliffe Adrian Director Aug 12 '26 Sale 5.29 12,700 67,183 0 Aug 13 09:00 PM TAKANASHI KEN Director Aug 11 '26 Sale 6.01 3,864 23,223 20,079 Aug 13 09:00 PM Tan Aik Na Director Aug 11 '26 Sale 6.01 432 2,596 24,968 Aug 13 09:00 PM ADRIAN G RAWCLIFFE Director Aug 12 '26 Proposed Sale 5.04 12,700 64,072 Aug 12 04:32 PM HEIDI L WAGNER Director Aug 11 '26 Proposed Sale 6.07 7,000 42,490 Aug 11 04:30 PM RA CAPITAL MANAGEMENT, L.P. Director Mar 26 '26 Buy 6.08 5,305,782 32,265,431 23,508,791 Mar 30 08:30 PM RA CAPITAL MANAGEMENT, L.P. Director Mar 27 '26 Buy 6.43 2,495,623 16,046,856 26,004,414 Mar 30 08:30 PM RA CAPITAL MANAGEMENT, L.P. Director Mar 30 '26 Buy 6.50 971,091 6,312,092 26,975,505 Mar 30 08:30 PM Francis Chris See Remarks Feb 26 '26 Option Exercise 4.28 33,194 141,920 79,767 Feb 27 09:00 PM Francis Chris See Remarks Feb 26 '26 Sale 15.05 33,194 499,593 61,867 Feb 27 09:00 PM Moran Kyle Chief Financial Officer Feb 09 '26 Sale 13.45 3,588 48,259 134,385 Feb 11 09:03 PM BOLNO PAUL President and CEO Feb 09 '26 Sale 13.45 10,480 140,956 275,520 Feb 11 09:02 PM Francis Chris See Remarks Feb 09 '26 Sale 13.45 1,883 25,326 61,867 Feb 11 09:01 PM Vargeese Chandra See Remarks Feb 09 '26 Sale 13.45 3,228 43,417 408,246 Feb 11 09:00 PM KYLE MORAN Officer Feb 09 '26 Proposed Sale 13.45 3,564 47,936 Feb 09 09:30 PM Chris Francis Officer Feb 09 '26 Proposed Sale 13.45 1,870 25,152 Feb 09 09:29 PM PAUL BOLNO Officer Feb 09 '26 Proposed Sale 13.45 10,411 140,028 Feb 09 09:27 PM Francis Chris See Remarks Jan 02 '26 Option Exercise 3.14 9,375 29,438 34,375 Jan 06 09:30 PM Francis Chris See Remarks Jan 02 '26 Sale 16.03 9,375 150,260 25,000 Jan 06 09:30 PM GSK plc 10% Owner Dec 11 '25 Buy 19.00 1,470,000 27,930,000 18,245,691 Dec 15 04:32 PM Rawcliffe Adrian Director Dec 08 '25 Option Exercise 5.97 42,000 250,740 54,700 Dec 10 09:45 PM Rawcliffe Adrian Director Dec 08 '25 Sale 15.00 42,000 630,000 12,700 Dec 10 09:45 PM Wagner Heidi L Director Dec 08 '25 Option Exercise 5.97 14,000 83,580 51,930 Dec 10 09:45 PM Wagner Heidi L Director Dec 08 '25 Sale 13.50 14,000 189,000 44,930 Dec 10 09:45 PM HENRY CHRISTIAN O Director Dec 08 '25 Option Exercise 5.07 87,000 440,790 54,700 Dec 10 09:45 PM HENRY CHRISTIAN O Director Dec 08 '25 Sale 14.65 93,445 1,369,324 12,700 Dec 10 09:45 PM Tan Aik Na Director Dec 08 '25 Option Exercise 4.85 119,230 578,270 70,400 Dec 10 09:45 PM Tan Aik Na Director Dec 08 '25 Sale 13.58 134,218 1,823,158 25,400 Dec 10 09:45 PM Verdine Gregory L. Director Dec 08 '25 Sale 13.47 20,000 269,461 275,217 Dec 10 09:45 PM Francis Chris See Remarks Dec 08 '25 Option Exercise 4.78 441,031 2,107,183 147,349 Dec 10 09:45 PM Francis Chris See Remarks Dec 08 '25 Sale 14.57 441,031 6,427,085 25,000 Dec 10 09:45 PM Moran Kyle Chief Financial Officer Dec 09 '25 Option Exercise 9.51 86,000 818,120 139,218 Dec 10 09:45 PM Moran Kyle Chief Financial Officer Dec 08 '25 Option Exercise 3.43 210,000 721,300 189,218 Dec 10 09:45 PM Moran Kyle Chief Financial Officer Dec 08 '25 Sale 14.77 210,000 3,102,000 89,218 Dec 10 09:45 PM Moran Kyle Chief Financial Officer Dec 09 '25 Sale 20.03 50,036 1,001,979 89,218 Dec 10 09:45 PM CORRIGAN MARK Director Dec 08 '25 Sale 13.48 16,115 217,297 28,815 Dec 10 09:45 PM KYLE MORAN Officer Dec 09 '25 Proposed Sale 18.52 86,000 1,592,720 Dec 09 04:24 PM Henry Family Trust Affiliate Dec 08 '25 Proposed Sale 18.52 93,445 1,730,601 Dec 08 07:08 PM HEIDI L WAGNER Director Dec 08 '25 Proposed Sale 7.49 14,000 104,860 Dec 08 04:39 PM KYLE MORAN Officer Dec 08 '25 Proposed Sale 7.49 210,000 1,572,900 Dec 08 04:37 PM CHRISTOPHER FRANCIS Officer Dec 08 '25 Proposed Sale 7.49 483,602 3,622,179 Dec 08 04:36 PM GREGORY VERDINE Director Dec 08 '25 Proposed Sale 7.49 20,000 149,800 Dec 08 04:35 PM ADRIAN RAWCLIFFE Director Dec 08 '25 Proposed Sale 7.49 42,000 314,580 Dec 08 04:34 PM MARK CORRIGAN Director Dec 08 '25 Proposed Sale 7.49 16,115 120,701 Dec 08 04:34 PM AIK NA TAN Director Dec 08 '25 Proposed Sale 13.58 134,218 1,823,158 Dec 08 04:29 PM
Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.
M.D. Dr. Paul B. Bolno M.B.A.
Founder & Director Dr. Gregory L. Verdine Ph.D.
CFO & Principal Accounting Officer Mr. Kyle B. Moran CFA
Chief Technology Officer Dr. Chandra Vargeese Ph.D.
Chief Strategy Officer Dr. Christopher Francis Ph.D.